Former U.S. President Donald Trump has rejected claims that he intends to raise prescription drug prices, stating instead that his goal is to make medicines more affordable for American citizens. Trump has long argued that people in the United States pay significantly more for the same drugs compared to patients in Europe and other developed countries.
Trump has emphasized that pharmaceutical companies should not be allowed to charge Americans higher prices than those paid abroad. During his presidency, he supported policies aimed at linking U.S. drug prices to the lowest prices available internationally, a move he says would force drugmakers to reduce costs in the American market.
While critics argue that such policies could lead to higher prices in other countries or affect the pharmaceutical industry’s profits, Trump maintains that his focus remains on protecting American consumers. He has repeatedly stated that any reforms would be designed to lower costs for patients, particularly seniors and low-income families.
Pharmaceutical companies have pushed back against price-control measures, warning that stricter regulations could impact innovation and research. Nevertheless, Trump has continued to call for tougher negotiations with drug manufacturers to ensure fair pricing.
In conclusion, Trump has made it clear that he does not support raising drug prices for Americans. His public statements and past actions indicate that reducing the cost of prescription medicines remains a central part of his healthcare agenda.
